Yangzhou, China, August 11th, 2023 – Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA).
Aurisco will attend CPHI Korea, 30 August - 1 September 2023, COEX, Seoul, Korea. #booth at L-35 #
Sirnaomics and Aurisco jointly explore opportunities and pathways to overcome challenges in the development and manufacturing of oligonucleotides, aiming to strengthening cooperation to accelerate the global launch of new oligonucleotides drugs.
Aurisco Pharmaceutical’s Oral Dydrogesterone Tablets Get Marketing Authorization Approval in China Under The Brand Name AUXITON.
Aurisco will Exhibit at CPHI South East Asia 12-14 July 2023 ，Queen Sirikit NationaConvention CenterBangkok, Thailand. Stand at #D70#
Follow Aoruite WeChat official account
